课题基金 / 基金详情

A synthetic biology approach to improve cell therapies by generating ischemia-resistant human pluripotent stem cell-derived cardiomyocytes

A synthetic biology approach to improve cell therapies by generating ischemia-resistant human pluripotent stem cell-derived cardiomyocytes
一种合成生物学方法,通过产生抗缺血的人多能干细胞衍生的心肌细胞来改善细胞疗法
批准号:
476220
负责人:
Murareanu Brandon
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-11-01 至 2025-11-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart attack is a potential life-threatening event that occurs as a common consequence of heart disease. There are over 15 million heart attacks every year, and heart disease is the leading cause of death worldwide. The damage caused to the heart followin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金